Asprosin and heart risk in rheumatoid arthritis
Part of Bones, joints & muscles, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study looks at a protein called asprosin in the blood of people with rheumatoid arthritis to see if it relates to metabolic problems (like high blood sugar or cholesterol) and heart risk. By joining, you may help doctors understand how to better protect the heart health of people with rheumatoid arthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have a diagnosis of rheumatoid arthritis (confirmed by a doctor using standard criteria).
- You must be willing to give written consent to join the study.
- You cannot have other autoimmune diseases (like lupus or scleroderma).
- You cannot have an active infection, be pregnant or breastfeeding, have a history of cancer, or have severe liver or kidney problems.
- You cannot be taking weight-loss medications or drugs that greatly change blood sugar or cholesterol (other than your standard rheumatoid arthritis treatment).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares heart health risks between two types of rheumatoid arthritis (RA): seronegative (without certain antibodies) and seropositive (with them). It aims to understand if heart risks differ between these groups, which could lead to better heart monitoring for RA patients.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study uses a special heart CT scan to look for early signs of heart disease in people with rheumatoid arthritis. It may help find problems before symptoms start.
This study tests whether an anti-inflammatory diet can help people with rheumatoid arthritis by lowering inflammation and disease activity. You may join if your symptoms are currently mild to moderate and you haven’t recently changed medications or your treatment plan.
This study looks at whether calcium in the heart arteries and a blood test (troponin) can help predict heart disease risk in people with rheumatoid arthritis. It may help doctors better prevent heart attacks and strokes.
This study looks at how oxidative stress (an imbalance of harmful molecules in the body) relates to cardiovascular risk in people with rheumatoid arthritis. It aims to see if these factors are linked, which could help in better managing heart health for RA patients.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.